Publications by authors named "Mohiuddin H Khan"
Background: Access to good-quality medicines in many countries is largely hindered by the rampant circulation of spurious/falsely labeled/falsified/counterfeit (SFFC) and substandard medicines. In 2006, the Ministry of Health of Cambodia, in collaboration with Kanazawa University, Japan, initiated a project to combat SFFC medicines.
Methods: To assess the quality of medicines and prevalence of SFFC medicines among selected products, a cross-sectional survey was carried out in Cambodia.
This study evaluated the quality and authenticity of the anti-influenza agent oseltamivir acquired via the Internet in Japan. The brand name drugs Tamiflu and Antiflu were obtained via the Internet using a search engine. The authenticity and legitimacy of the medicines were verified with the samples' manufacturers and the regulatory authorities of the country of origin, respectively.
View Article and Find Full Text PDFBackground: The use of substandard and degraded medicines is a major public health problem in developing countries such as Cambodia. A collaborative study was conducted to evaluate the quality of amoxicillin-clavulanic acid preparations under tropical conditions in a developing country.
Methods: Amoxicillin-clavulanic acid tablets were obtained from outlets in Cambodia.
Objective: To explore the circulation of anti-obesity medicines via the internet and their quality.
Design: Cross-sectional study.
Setting: Internet pharmacies and pharmaceutical suppliers accessible from Japan.
Background: Recent investigations by the Ministry of Health of Cambodia suggest that counterfeit medicines have been introduced into the pharmaceutical market in tampered packaging. To further explore this possibility, an interview survey was conducted at the wholesaler level to investigate the medicinal supply chain in Cambodia.
Methods: Managing executives of 62 (83.
Article Synopsis
- * Researchers collected samples from 137 private drug outlets and found that 15.8% of registered medicines were not actually registered, with 4.2% of the tested samples confirmed as counterfeit.
- * The findings highlight the urgent need for stricter drug registration practices and monitoring to tackle the problem of counterfeit medicines in the country.